%0 Journal Article
%T Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway
%A Hua Tang
%A Ke Chen
%A Xiangnan Hu
%A Xuefeng Shan
%A Yuyang Liu
%J Archive of "Cancer Cell International".
%D 2019
%R 10.1186/s12935-019-0732-2
%X The online version of this article (10.1186/s12935-019-0732-2) contains supplementary material, which is available to authorized users
%K Rosiglitazone metformin adduct
%K Hepatocellular carcinoma
%K Proliferation
%K Metformin
%K AMPK/p21 pathway
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330460/